Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy
Peptide-functionalized nanomedicine, which addresses the challenges of specificity and efficacy in drug delivery, is emerging as a pivotal approach for cancer therapy. Globally, cancer remains a leading cause of mortality, and conventional treatments, such as chemotherapy, often lack precision and c...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/1/202 |
_version_ | 1827369712513712128 |
---|---|
author | Kibeom Kim Myoung-Hwan Park |
author_facet | Kibeom Kim Myoung-Hwan Park |
author_sort | Kibeom Kim |
collection | DOAJ |
description | Peptide-functionalized nanomedicine, which addresses the challenges of specificity and efficacy in drug delivery, is emerging as a pivotal approach for cancer therapy. Globally, cancer remains a leading cause of mortality, and conventional treatments, such as chemotherapy, often lack precision and cause adverse effects. The integration of peptides into nanomedicine offers a promising solution for enhancing the targeting and delivery of therapeutic agents. This review focuses on the three primary applications of peptides: cancer cell-targeting ligands, building blocks for self-assembling nanostructures, and elements of stimuli-responsive systems. Nanoparticles modified with peptides improved targeting of cancer cells, minimized damage to healthy tissues, and optimized drug delivery. The versatility of self-assembled peptide structures makes them an innovative vehicle for drug delivery by leveraging their biocompatibility and diverse nanoarchitectures. In particular, the mechanism of cell death induced by self-assembled structures offers a novel approach to cancer therapy. In addition, peptides in stimuli-responsive systems enable precise drug release in response to specific conditions in the tumor microenvironment. The use of peptides in nanomedicine not only augments the efficacy and safety of cancer treatments but also suggests new research directions. In this review, we introduce systems and functionalization methods using peptides or peptide-modified nanoparticles to overcome challenges in the treatment of specific cancers, including breast cancer, lung cancer, colon cancer, prostate cancer, pancreatic cancer, liver cancer, skin cancer, glioma, osteosarcoma, and cervical cancer. |
first_indexed | 2024-03-08T09:56:27Z |
format | Article |
id | doaj.art-066d16e119b5408b85ac25033494cbdb |
institution | Directory Open Access Journal |
issn | 2227-9059 |
language | English |
last_indexed | 2024-03-08T09:56:27Z |
publishDate | 2024-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Biomedicines |
spelling | doaj.art-066d16e119b5408b85ac25033494cbdb2024-01-29T13:47:51ZengMDPI AGBiomedicines2227-90592024-01-0112120210.3390/biomedicines12010202Role of Functionalized Peptides in Nanomedicine for Effective Cancer TherapyKibeom Kim0Myoung-Hwan Park1Convergence Research Center, Nanobiomaterials Institute, Sahmyook University, Seoul 01795, Republic of KoreaConvergence Research Center, Nanobiomaterials Institute, Sahmyook University, Seoul 01795, Republic of KoreaPeptide-functionalized nanomedicine, which addresses the challenges of specificity and efficacy in drug delivery, is emerging as a pivotal approach for cancer therapy. Globally, cancer remains a leading cause of mortality, and conventional treatments, such as chemotherapy, often lack precision and cause adverse effects. The integration of peptides into nanomedicine offers a promising solution for enhancing the targeting and delivery of therapeutic agents. This review focuses on the three primary applications of peptides: cancer cell-targeting ligands, building blocks for self-assembling nanostructures, and elements of stimuli-responsive systems. Nanoparticles modified with peptides improved targeting of cancer cells, minimized damage to healthy tissues, and optimized drug delivery. The versatility of self-assembled peptide structures makes them an innovative vehicle for drug delivery by leveraging their biocompatibility and diverse nanoarchitectures. In particular, the mechanism of cell death induced by self-assembled structures offers a novel approach to cancer therapy. In addition, peptides in stimuli-responsive systems enable precise drug release in response to specific conditions in the tumor microenvironment. The use of peptides in nanomedicine not only augments the efficacy and safety of cancer treatments but also suggests new research directions. In this review, we introduce systems and functionalization methods using peptides or peptide-modified nanoparticles to overcome challenges in the treatment of specific cancers, including breast cancer, lung cancer, colon cancer, prostate cancer, pancreatic cancer, liver cancer, skin cancer, glioma, osteosarcoma, and cervical cancer.https://www.mdpi.com/2227-9059/12/1/202cancer therapyfunctionalizationnanomedicinenanoparticlepeptide |
spellingShingle | Kibeom Kim Myoung-Hwan Park Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy Biomedicines cancer therapy functionalization nanomedicine nanoparticle peptide |
title | Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy |
title_full | Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy |
title_fullStr | Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy |
title_full_unstemmed | Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy |
title_short | Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy |
title_sort | role of functionalized peptides in nanomedicine for effective cancer therapy |
topic | cancer therapy functionalization nanomedicine nanoparticle peptide |
url | https://www.mdpi.com/2227-9059/12/1/202 |
work_keys_str_mv | AT kibeomkim roleoffunctionalizedpeptidesinnanomedicineforeffectivecancertherapy AT myounghwanpark roleoffunctionalizedpeptidesinnanomedicineforeffectivecancertherapy |